Skip to main content

Table 3 Tolerance

From: Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

  Non-compliant Compliant Total
  N % N % N %
Very bad 9 14.3 9 10.1 18 11.8
Bad 10 15.9 8 9.0 18 11.8
Indifferent 13 20.6 29 32.6 42 27.6
Good 21 33.3 27 30.3 48 31.6
Very good 10 15.9 16 18.0 26 17.1
Total 63 100.0 89 100.0 152 100.0